Reuters logo
BRIEF-Cumberland Pharmaceuticals Q4 revenue rose 13 pct to $9.1 mln
March 7, 2017 / 9:58 PM / 7 months ago

BRIEF-Cumberland Pharmaceuticals Q4 revenue rose 13 pct to $9.1 mln

March 7 (Reuters) - Cumberland Pharmaceuticals Inc:

* Cumberland Pharmaceuticals Inc - reports FY 2016 adjusted earnings $0.11 per share

* Cumberland Pharmaceuticals reports fourth quarter and full year 2016 financial results

* Q4 revenue rose 13 percent to $9.1 million

* Qtrly loss per share attributable to common shareholders $0.05 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below